Understanding How Opioids Affect the Experiential and Neural Signatures of Social Experiences
Recruiting
Early Phase 1
Interventional Study
Naltrexone
Placebo
Healthy Volunteers Welcome
You do not need to have the condition being studied to take part.
At a Glance
- Age
- 18 – 25
- Sex
- Any
- Trial phase
- Early Phase 1
- Study type
- Interventional
- Purpose
- Basic Science
- Participants needed
- 210 (estimated)
- Sponsor
- San Diego State University · Other
Think this trial could be right for you?
Answer a few quick questions to see if you may meet the eligibility requirements.
Check Your Eligibility
About This Trial
The study is a randomized, placebo-controlled design with the opioid antagonist, oral naltrexone. Following random assignment, participants will take 50mg of naltrexone or placebo once a day for 7 days. On days 1 - 7, participants complete reports of their feelings of social connection and mood in order to assess more naturalistic feelings in response to opportunities for social connection outside…
Trial Locations
Loading…
Loading trial locations…
Eligibility Criteria
Inclusion Criteria:
* good health
* English fluency
* willing to provide contact information for 4-6 close others
* willing to provide digital photographs of 2 close others
* own a smartphone
Exclusion Criteria:
* presence of medical devices, implants, or other metal objects in or on the body tha…
Contacts